Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cosset

Showing results (301-310 of 637) with videos related to

Pageof 64
Sort By:
Bulletin Du Cancer|January 1, 1991
[Immediate hematologic tolerance of extended irradiations after chemotherapy. Apropos of 78 cases of Hodgkin's disease stage III and IV without marrow involvement treated at the Gustave-Roussy Institute]J Y Pierga, J Y Follezou, M Chelfi, et al.
Leukemia & Lymphoma|December 1, 1995
Successful chemotherapy including epirubicin in a pregnant non-Hodgkin's lymphoma patientF Goldwasser, J L Pico, J Cerrina, et al.
Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique|January 1, 1990
[Malignant non-Hodgkin's lymphoma of the conjunctiva. Apropos of 14 cases treated at the Institut Gustave-Roussy]L Vitu, J M Cosset, E Briot, et al.
Journal of Virology|March 1, 1996
Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SUS Valsesia-Wittmann, F J Morling, B H Nilson, et al.
Plos Pathogens|December 19, 2017
The amino-terminus of the hepatitis C virus (HCV) p7 viroporin and its cleavage from glycoprotein E2-p7 precursor determine specific infectivity and secretion levels of HCV particle typesSolène Denolly, Chloé Mialon, Thomas Bourlet, et al.
Cancer Immunology, Immunotherapy : CII|November 8, 2021
Efficient adoptive transfer of autologous modified B cells: a new humanized platform mouse model for testing B cells reprogramming therapiesAudrey Page, Emilie Laurent, Didier Nègre, et al.
Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique|January 1, 1990
[Predictive tests of radiocurability: towards a custom-made radiotherapy?]J M Cosset, L J Peters, T Girinsky, et al.
The Journal of General Virology|September 28, 2005
Contribution of the charged residues of hepatitis C virus glycoprotein E2 transmembrane domain to the functions of the E1E2 heterodimerYann Ciczora, Nathalie Callens, Claire Montpellier, et al.
Vaccine|February 17, 2006
DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvantBertrand Bellier, Charlotte Dalba, Béatrice Clerc, et al.
Oncology|November 1, 1993
Neoadjuvant chemotherapy with carboplatin/5-fluorouracil in head and neck cancerJ Depondt, P Gehanno, M Martin, et al.
Pageof 64

Showing results (301-310 of 637) with videos related to

Sort By:
Pageof 64
Bulletin Du Cancer|January 1, 1991
[Immediate hematologic tolerance of extended irradiations after chemotherapy. Apropos of 78 cases of Hodgkin's disease stage III and IV without marrow involvement treated at the Gustave-Roussy Institute]J Y Pierga, J Y Follezou, M Chelfi, et al.
Leukemia & Lymphoma|December 1, 1995
Successful chemotherapy including epirubicin in a pregnant non-Hodgkin's lymphoma patientF Goldwasser, J L Pico, J Cerrina, et al.
Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique|January 1, 1990
[Malignant non-Hodgkin's lymphoma of the conjunctiva. Apropos of 14 cases treated at the Institut Gustave-Roussy]L Vitu, J M Cosset, E Briot, et al.
Journal of Virology|March 1, 1996
Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SUS Valsesia-Wittmann, F J Morling, B H Nilson, et al.
Plos Pathogens|December 19, 2017
The amino-terminus of the hepatitis C virus (HCV) p7 viroporin and its cleavage from glycoprotein E2-p7 precursor determine specific infectivity and secretion levels of HCV particle typesSolène Denolly, Chloé Mialon, Thomas Bourlet, et al.
Cancer Immunology, Immunotherapy : CII|November 8, 2021
Efficient adoptive transfer of autologous modified B cells: a new humanized platform mouse model for testing B cells reprogramming therapiesAudrey Page, Emilie Laurent, Didier Nègre, et al.
Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique|January 1, 1990
[Predictive tests of radiocurability: towards a custom-made radiotherapy?]J M Cosset, L J Peters, T Girinsky, et al.
The Journal of General Virology|September 28, 2005
Contribution of the charged residues of hepatitis C virus glycoprotein E2 transmembrane domain to the functions of the E1E2 heterodimerYann Ciczora, Nathalie Callens, Claire Montpellier, et al.
Vaccine|February 17, 2006
DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvantBertrand Bellier, Charlotte Dalba, Béatrice Clerc, et al.
Oncology|November 1, 1993
Neoadjuvant chemotherapy with carboplatin/5-fluorouracil in head and neck cancerJ Depondt, P Gehanno, M Martin, et al.
Pageof 64